Oncologix Tech, Inc. announced a private placement of a promissory note for gross proceeds of $100,000 with a non-affiliated accredited Investor on July 26, 2013. The company issued an additional 2,500 series D convertible preferred stock in the transaction. The note carries a coupon of 18% per annum and would mature on January 26, 2015.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0002 USD | -.--% | -.--% | -92.00% |
2022 | DNAGO.Ai entered into a definitive business combination agreement to acquire Oncologix Tech, Inc. in a reverse merger transaction. | CI |
2016 | Oncologix Tech, Inc. Announces Management Changes | CI |
1st Jan change | Capi. | |
---|---|---|
-92.00% | 332K | |
+160.99% | 8.26B | |
+2.33% | 983M | |
+41.91% | 883M | |
+20.77% | 806M | |
+2.20% | 667M | |
+4.13% | 626M | |
-.--% | 600M | |
+8.61% | 529M | |
-.--% | 500M |
- Stock Market
- Equities
- OCLG Stock
- News Oncologix Tech, Inc.
- Oncologix Tech, Inc. announced that it has received $0.1 million in funding